In particular, ACE2 plays a bifunctional role as a sort of “double-edged sword”; it turns off the RAS and leads to beneficial effects but also mediates unique susceptibility to lung and cardiovascular disease in COVID-19 patients by serving as the SARS-CoV-2 receptor. This evidence concerns the gene ACE2 and COVID-19.